Importantly, nearly all (> 99%) of the infiltrating CD45high population were GFPlow, suggesting that Tmem119 is microglia-specific and is not expressed on tumor-infiltrating peripheral myeloid cells. This evidence concerns the gene TMEM119 and neoplasm.